DWA
CRL icon

Douglass Winthrop Advisors’s Charles River Laboratories CRL Stock Holding History

Douglass Winthrop Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,000
Closed -$337K – 259
2018
Q2 		$337K Buy
+3,000
New +$324K 0.02% 226

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Douglass Winthrop Advisors's CRL Position: Q3 2018 in Review

Douglass Winthrop Advisors sold out of Charles River Laboratories (CRL) in Q3 2018, closing a stake of 3,000 shares — an estimated $337K sold.

Douglass Winthrop Advisors first reported a position in CRL in Q2 2018 and held it in 1 quarter. The position peaked at $337K in Q2 2018. 366 funds tracked by Wall St. Rank hold CRL as of Q3 2018.

  • Douglass Winthrop Advisors reported no remaining Charles River Laboratories position as of Q3 2018 after selling out during the quarter.
  • Douglass Winthrop Advisors sold 3,000 Charles River Laboratories shares in Q3 2018, an estimated $337K.
  • Douglass Winthrop Advisors first reported a position in Charles River Laboratories in Q2 2018 and held it in 1 quarter.
  • Douglass Winthrop Advisors's Charles River Laboratories position peaked at $337K in Q2 2018.
  • 366 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2018.

Based on Douglass Winthrop Advisors's 13F filing for Q3 2018, filed 12 Oct 2018.